{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T01:44:35Z","timestamp":1697679875924},"reference-count":9,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ejphar.2006.11.016","type":"journal-article","created":{"date-parts":[[2006,11,15]],"date-time":"2006-11-15T21:28:15Z","timestamp":1163626095000},"page":"151-153","source":"Crossref","is-referenced-by-count":26,"title":["Dopamine partial agonist action of (\u2212)OSU6162 is consistent with dopamine hyperactivity in psychosis"],"prefix":"10.1016","volume":"557","author":[{"given":"Philip","family":"Seeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Chang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2006.11.016_bib1","first-page":"137","article-title":"A dopaminergic deficit hypothesis of schizophrenia: the path to discovery","volume":"8","author":"Carlsson","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2006.11.016_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2006.01.051","article-title":"Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release","volume":"535","author":"Cosi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.11.016_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","article-title":"Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain","volume":"493","author":"Li","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2006.11.016_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1124\/jpet.106.102905","volume":"318","author":"Natesan","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2006.11.016_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.mp.4001682","article-title":"Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics","volume":"10","author":"Seeman","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2006.11.016_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2High dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2006.11.016_bib7","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/jm00043a013","article-title":"Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure\u2013activity relationships","volume":"37","author":"Sonesson","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2006.11.016_bib8","first-page":"531","article-title":"(\u2212)OSU6162, a representative from a unique class of functional modulators of dopaminergic systems","volume":"23","author":"Sonesson","year":"1997","journal-title":"Abstr. - Soc. Neurosci."},{"key":"10.1016\/j.ejphar.2006.11.016_bib9","series-title":"Neuro-Psycho-Pharmacology, Proceedings of the 5th Int. Congress of the Collegium Internationale Neuro-Psycho-pharmacologicum, March 1966","first-page":"321","article-title":"The significance of dopamine-receptor blockade for the action of neuroleptic drugs","author":"Van Rossum","year":"1967"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906012817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299906012817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T08:20:16Z","timestamp":1547194816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299906012817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":9,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0014299906012817"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}